[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
November 10, 2015

Improving Awareness and Outcomes Related to Venous Thromboembolism

Author Affiliations
  • 1Cardiovascular Research Institute of Vermont, Department of Medicine, University of Vermont College of Medicine, Burlington
  • 2Thrombosis and Hemostasis Program, University of Vermont Medical Center, Burlington
  • 3Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire
JAMA. 2015;314(18):1913-1914. doi:10.1001/jama.2015.15107

Over the last 2 decades, understanding of risk factors, prevention, and acute and long-term treatment of venous thromboembolism (VTE) have increased substantially. This disorder, comprising deep vein thrombosis (DVT) and pulmonary embolism, is the third leading vascular diagnosis after myocardial infarction and stroke, contributes to at least 3.2% of cardiovascular-related deaths in the United States (43 579 cases) and may affect 300 000 to 600 000 individuals annually.1 Surveillance for fatal and nonfatal VTE is not performed in the United States, so these statistics are imprecise.

First Page Preview View Large
First page PDF preview
First page PDF preview
×